Walmart has introduced the first private brand analog insulin product, which, according to the company, is a first in diabetes care, and will provide a significant cost savings. The product is called ReliOn NovoLog, and it is sold under Walmart’s private label brand ReliOn.
ReliOn NovoLog will also provide customers with analog insulin vials and FlexPens with savings between 58% to 75% off the price of branded analog insulin products. The prices are based on out-of-pocket costs that patients pay for insulin without a prescription drug insurance. ReliOn NovoLog Insulin (insulin aspart), manufactured by Novo Nordisk, is now available in Walmart pharmacies and will begin being sold at Sam’s Club pharmacies in mid-July across the United States.
According to the Center for Disease Control, over 34 million Americans, or 10% of the population, have been diagnosed with diabetes and another 88 million are classified as prediabetic.
According to the Center for Disease Control, over 34 million Americans, or 10% of the population, have been diagnosed with diabetes and another 88 million are classified as prediabetic.